Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fi...
To pick up a draggable item, press the space bar.
While dragging, use the arrow keys to move the item.
Press space again to drop the item in its new position, or press escape to cancel.
Peer Benchmarks
Quote
Value
Size
Growth
Profit
A288330
Peers
Sector
Market Cap
411.7 B
98.361 B
94.559 B
Price % of 52 Week High
92.3%
46.5%
62.1%
Dividend Yield
0.0%
0.0%
0.0%
Shareholder Yield
-5.7%
-7.9%
-0.7%
1 Year Price Total Return
110.6%
-30.6%
-12.1%
Beta (5 Year)
0.94
0.66
0.64
In the News
Fair Value
Average
4,072.46
Downside
-47.8%
Uncertainty
VERY HIGH
Spread
3,208.48 - 4,936.44
Market Range
52 weeks
₩1,464
₩8,670
₩7,800
Analyst Targets
0 analysts
-
Investing Models
₩3,208
₩4,936
₩4,072
Financial Health
Financial Health for Bridge Bio is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Frontier economic markets.
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key